Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Esophageal Neoplasms 1 Digestive System Abnormalities 1

Interventions

Fluorouracil 13 pembrolizumab 12 Paclitaxel 12 Oxaliplatin 12 Leucovorin 9 Carboplatin 9 Capecitabine 8 Trastuzumab 7 Nivolumab 7 Cisplatin 7 Radiotherapy 6 Radiation 6 Taxes 5 Esophagectomy 5 Drug Therapy 5 Surgical Procedures, Operative 4 Specimen Handling 4 Irinotecan 4 trastuzumab deruxtecan 3 tislelizumab 3 patritumab deruxtecan 3 Radiotherapy, Intensity-Modulated 3 Proton Therapy 3 Immunotherapy 3 zanidatamab 2 ulixertinib 2 trastuzumab biosimilar HLX02 2 relatlimab 2 durvalumab 2 atezolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Amyloid × 90 days × Clear all

NCT02530983 2026-03-30

UDD

Mayo Clinic

Gastrointestinal

Digestive System Abnormalities, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡